Regulating protein translation to protect from UV-induced damage

Lead Research Organisation: University of Cambridge
Department Name: Wellcome Trust - MRC Cam Stem Cell Inst

Abstract

Skin is the barrier that protects our body against the external environment, but chronic exposure to ultraviolet (UV) light causes skin inflammation, aging and cancer. The maintenance of the skin epidermis is tightly balanced and controlled by stem cells that continuously maintain their population (self-renewal) while generating progeny (differentiation). Skin stem cells are established during development and are retained in adulthood allowing the body to replace, restore and regenerate dead, damaged or diseased epidermal cells. Our research plan is designed to (i) analyze the specific contribution of epidermal stem cell to regenerate UV-exposed skin and (ii) identify novel intrinsic key factors that promote cell survival in response to UV-damage. Our research will improve our current understanding of how a healthy skin is maintained and will lead to novel discoveries with important implications for regenerative medicine in particular for skin repair, aging and cancer.

Technical Summary

Post-transcriptional regulation of gene expression ultimately determines the rate of protein translation and is therefore crucial for virtually all cellular processes. Global reduction of protein synthesis is a well-known early response to UV-stress, yet the intrinsic selective mechanisms that subsequently determine cell death or survival are largely unknown. We propose to decipher the functional roles of protein synthesis in regulating epidermal stem cell fate by determining the global and specific protein translation rates in response to UV-exposure in vivo. We will then evaluate the importance of post-transcriptional methylation pathways in mediating cell survival under UV-stress. Using a combination of system-wide approaches, mouse models and in vitro differentiation assays, we propose to (1) measure protein production in distinct UV-radiated epidermal stem cell populations; (2) profile the translational landscape of UV-radiated epidermal stem cell populations; (3) identify cytosine-5 RNA methylation as regulatory mechanism to promote cell survival in response to UV-stress. Our comprehensive approach will answer how protein synthesis contributes to the UV-stress response and might lead to the discovery of novel therapeutic strategies for skin diseases, aging and cancer.

Planned Impact

The potential beneficiaries of the proposed research grant are (1) the broad scientific community, (2) the public, and (3) patients affected by skin regenerative diseases and cancer.

Exposure to environmental hazards such as ultraviolet radiation (UV) affects every human being: Intense exposure to UV-radiation is the primary cause of skin cancer and less intense but chronic exposure to UV-light is thought to be main cause of skin aging. The identification of novel pathways and key regulators that promote skin regeneration in response to UV can potential contribute the nations health and enhance the quality of live. For instance, we will identify novel protein candidates and test whether they promote cell survival and skin regeneration in response to UV-stress. Because we will focus on protein candidates, for which small inhibitors are already available, we may well identify novel therapeutic strategies for skin regeneration over the course of this grant.
 
Description Research Grant-Worldwide Cancer Research Award
Amount £199,799 (GBP)
Funding ID 15-0168 
Organisation World Cancer Research Fund 
Sector Charity/Non Profit
Country Global
Start 01/2015 
End 12/2018
 
Description Identification of RNA methylation inhibitors using small molecules 
Organisation STORM Therapeutics Ltd
Country United Kingdom 
Sector Private 
PI Contribution Consultancy on the screen and the cellular function of RNA methylases.
Collaborator Contribution Performing high throughput screen to identify RNA methylation inhibitors.
Impact Research tools for our experiments and mass spec analyses
Start Year 2017
 
Description Identification of RNA methylation inhibitors using transition state analogs 
Organisation Pasteur Institute, Paris
Country France 
Sector Charity/Non Profit 
PI Contribution Testing the inhibitors in cell based assays
Collaborator Contribution Providing the compounds and optimizing potential hits.
Impact RNA methylation inhibitors
Start Year 2017
 
Description Identification of m5C 'reader' proteins 
Organisation Wellcome Trust
Department Wellcome Trust Centre for Cell Biology
Country United Kingdom 
Sector Charity/Non Profit 
PI Contribution Sharing novel assays in identifying novel m5C reader proteins using mass-spectrometry approaches.
Collaborator Contribution Sharing reagents, protocols and expertise.
Impact N/A
Start Year 2013
 
Description RNA methylation in mitocondria 
Organisation Medical Research Council (MRC)
Department MRC Mitochondrial Biology Unit
Country United Kingdom 
Sector Academic/University 
PI Contribution Functional relevance of NSUN3 RNA methylase in mitochondria
Collaborator Contribution Exchange of patient cells and technics
Impact Publication Grant proposal (pending)
Start Year 2014
 
Description "My life as a scientist" 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach Local
Primary Audience Schools
Results and Impact "My life as a scientist" was an interactive presentation to Year 4 pupils at the St Faith school in Cambridge
Year(s) Of Engagement Activity 2017
 
Description Berlin Translational Dialogue to explore possibilities of translational medicine 
Form Of Engagement Activity A formal working group, expert panel or dialogue
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Other audiences
Results and Impact Berlin Translational Dialogue to explore possibilities of translational medicine organized by Elsevier. In conjunction with Falling Walls Conference 2015, Elsevier organized the "Translational Dialogue: Interactive Workshop & Panel Discussion' with focus on the best research & new approaches for future medicine.
Year(s) Of Engagement Activity 2015
 
Description Berlin Translational Dialogue to explore possibilities of translational medicine 
Form Of Engagement Activity A formal working group, expert panel or dialogue
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Other audiences
Results and Impact Presentation at the Berlin Translational Dialogue to explore possibilities of translational medicine.
Year(s) Of Engagement Activity 2015
URL https://www.elsevier.com/connect/berlin-translational-dialogue-will-explore-possibilities-of-transla...
 
Description Career talk for CRUK fellows 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Other audiences
Results and Impact Career advice for CR-UK fellows.
Year(s) Of Engagement Activity 2010,2012,2016
 
Description Pint of Science 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach Local
Primary Audience Public/other audiences
Results and Impact Interactive and critical discussion on the the subject "Stem Cells - Key to life or overrated?"
Year(s) Of Engagement Activity 2015
 
Description Presentation 
Form Of Engagement Activity A formal working group, expert panel or dialogue
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Other audiences
Results and Impact Berlin Future Medicine - The local newpaper "Tagesspiegel" and the Berlin Institute of Health, together with Charité - Universitätsmedizin Berlin and Max Delbrück Center for Molecular Medicine, featured international scientists to present their visions of the future of medicine.
Year(s) Of Engagement Activity 2017
URL https://science-match.tagesspiegel.de/future-medicine-2017